Statistics

Total Visits

Views
A phase I study of olaratumab, an anti-platelet-derived growth factor receptor alpha (PDGFRα) monoclonal antibody, in patients with advanced solid tumors 94
A phase I study of olaratumab, an anti-platelet-derived growth factor receptor alpha (PDGFRα) monoclonal antibody, in patients with advanced solid tumors 48

Total Visits per Month

November 2023 December 2023 January 2024 February 2024 March 2024 April 2024 May 2024
A phase I study of olaratumab, an anti-platelet-derived growth factor receptor alpha (PDGFRα) monoclonal antibody, in patients with advanced solid tumors 4 2 5 0 7 9 8

File Downloads

Views

Top Country Views

Views
United States 60
Australia 24
China 12
Netherlands 8
France 6
Singapore 6
Vietnam 5
Ireland 4
Argentina 3
Sweden 3

Top City Views

Views
Ashburn 24
Kaleen 14
Rotterdam 8
Cambridge 5
Fairfield 5
Hanoi 5
Dublin 4
Singapore 4
San Jose 3
Zhengzhou 3